Company / Operating Cash Flow
Apyx Medical Corp Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$8.0M
FY2025
5-year range
-$20.3M / -$8.0M
FY2021-FY2025
Trend
+55.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$20M in FY2023 to -$417,000 in FY2016.
Based on SEC 10-K filings.
-$8M in FY2025.
Improved from -$20M to -$8M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 55.7% year-over-year.
- Peak operating cash flow was recorded in FY2016.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$8.0M | +55.7% |
| FY2024 | -$18.0M | +11.0% |
| FY2023 | -$20.3M | +0.0% |
| FY2022 | -$20.3M | -26.2% |
| FY2021 | -$16.1M | +13.0% |
| FY2020 | -$18.5M | -398.8% |
| FY2019 | -$3.7M | -30.6% |
| FY2018 | -$2.8M | +51.0% |
| FY2017 | -$5.8M | -1287.5% |
| FY2016 | -$417.0K | +83.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026